Hackensack Meridian Health Hackensack University Medical Center
Clinical research site in Hackensack, New Jersey · 30 PROSPECT AVE, HACKENSACK, NJ 07601-1914 · (201) 996-2210
Part of Hackensack Meridian Health
As of September 2026, 17 paid clinical trials are recruiting at Hackensack Meridian Health Hackensack University Medical Center in Hackensack, New Jersey. Active studies at this site cover conditions such as Myelodysplastic Syndromes, Acute Myeloid Leukemia and Alzheimer Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Hackensack Meridian Health Hackensack University Medical Center (17)
Pompe Disease Registry Protocol
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
ED Medicaid Support
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Get new-trial alerts for Hackensack Meridian Health Hackensack University Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Hackensack, NJ. Unsubscribe anytime.
More research sites in Hackensack
- Hackensack University Medical Center (122 trials)
- John Theurer Cancer Center at Hackensack University Medical Center (44 trials)
- John Theurer Cancer Center (13 trials)
- Hackensack Meridian Health (11 trials)
- John Theurer Cancer Center at Hackensack UMC (7 trials)
- John Theurer Cancer Center Hackensack University Medical Center (6 trials)
- Northeast Regional Epilepsy Group (6 trials)
- Hackensack Medical Center (5 trials)
- Hackensack Meridian Health (Data collection only) (4 trials)
- Hackensack Meridian Health - Hackensack University Medical Center (4 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Hackensack, NJ · New Jersey clinical trials